| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/01/2011 | US20110212069 Modulation of Microglia Activation |
| 09/01/2011 | US20110212068 Methods and compositions for treating congestive heart failure |
| 09/01/2011 | US20110212059 Paramyxovirus vector encoding angiogenesis gene and use thereof |
| 09/01/2011 | US20110212053 Phosphatidylinositol 3 kinase inhibitors |
| 09/01/2011 | US20110212051 Variants of vascular endothelial growth factor (vegf) receptor and use thereof |
| 09/01/2011 | US20110212047 Polymer Therapy for the Treatment of Chronic Microvascular Diseases |
| 09/01/2011 | CA2791331A1 Modulation of angiogenesis |
| 09/01/2011 | CA2791164A1 Adhesive patch containing bisoprolol |
| 09/01/2011 | CA2791114A1 Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions |
| 09/01/2011 | CA2791100A1 Bisaryl-bonded aryltriazolones and use thereof |
| 09/01/2011 | CA2790993A1 Pyrrolidine substituted flavones for the treatment of inflammatory disorders |
| 09/01/2011 | CA2790817A1 Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation |
| 09/01/2011 | CA2790610A1 Biodegradable material containing silicon, for pro-angiogenetic therapy |
| 09/01/2011 | CA2789458A1 Selenalzole derivative having ligand which activates peroxisome proliferator activated receptor (ppar), preparing method thereof and usage of the chemical compounds |
| 09/01/2011 | CA2789064A1 Capsule of compound danshen dripping pills |
| 08/31/2011 | EP2361970A1 Method of enhancing proliferation and/or survival of mesenchymal precursor cells (MPC) |
| 08/31/2011 | EP2361910A1 Compound having tafia inhibitory activity |
| 08/31/2011 | EP2361907A1 The five crystal forms of the nicousamide, the preparation methods, the pharmaceutical compositions and the uses thereof |
| 08/31/2011 | EP2361633A1 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 08/31/2011 | EP2361631A1 Treatment of alpha-galactosidase a deficiency |
| 08/31/2011 | EP2361625A1 Methods and compositions for the treatment of hyperlipidemia |
| 08/31/2011 | EP2361306A1 Compositions and methods for selective inhibition of pro-angiogenic vegf isoforms |
| 08/31/2011 | EP2187915B1 Use of the peptide phpfhlfvy (renin inhibitor) in anti-angiogenic therapy of certain diseases |
| 08/31/2011 | EP2031057B1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 08/31/2011 | EP1984345B1 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents |
| 08/31/2011 | CN1985846B Use of brown algae polyose sulfate in preparing medicine for treating cardic and cerebral vascular diseases |
| 08/31/2011 | CN1946726B Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics |
| 08/31/2011 | CN1914194B Therapeutic agent for vasospasm accompanying bypass operation |
| 08/31/2011 | CN1659162B Tricyclic thrombin receptor antagonists |
| 08/31/2011 | CN102171214A Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) |
| 08/31/2011 | CN102171204A 8-substituted isoquinoline derivative and use thereof |
| 08/31/2011 | CN102171193A Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid |
| 08/31/2011 | CN102171187A PSMA-binding agents and uses thereof |
| 08/31/2011 | CN102170885A Pharmaceutical composition for oral administration |
| 08/31/2011 | CN102170883A Compounds useful as inhibitors of protein kinases |
| 08/31/2011 | CN102170875A Chewing gum containing low dose amounts of water soluble vitamins |
| 08/31/2011 | CN102170872A Method of modulating membrane potential of a cell |
| 08/31/2011 | CN102168062A Human pulmonary artery smooth muscle cell separation and culturing method and application of same |
| 08/31/2011 | CN102167753A Preparation method of oat beta-glucan |
| 08/31/2011 | CN102167697A Novel structure, synthesis method and application of hypoxia injury resistant compounds |
| 08/31/2011 | CN102167690A Icariin aglucone derivative and preparation method and application thereof |
| 08/31/2011 | CN102167685A 4-(2'-n-butyl-4,5-disubstituted-2,4'-bis-imidazole-3'-methyl) benzoic acid derivative |
| 08/31/2011 | CN102166358A Use of inhibitors of jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases |
| 08/31/2011 | CN102166357A Medicinal composition containing bicyclic aza-alkane derivative |
| 08/31/2011 | CN102166346A Lrrc10 micromolecules and application thereof to preparation of medicaments for treating myocardial hypertrophy |
| 08/31/2011 | CN102166332A Traditional Chinese medicament compound for treating angina |
| 08/31/2011 | CN102166331A Medicament for treating hemorrhoids and preparation method thereof |
| 08/31/2011 | CN102166287A Recovery mud moxibustion and preparation method |
| 08/31/2011 | CN102166272A Medicament for treating hemorrhoids and preparation method thereof |
| 08/31/2011 | CN102166269A Method for extracting flavones from waste slags of citrus bergamot drink |
| 08/31/2011 | CN102166262A Chinese herbal preparation for adjusting blood pressure |
| 08/31/2011 | CN102166256A Liver-warming and heart-easing capsules |
| 08/31/2011 | CN102166248A Rape pollen extract and preparation method and application thereof |
| 08/31/2011 | CN102166247A Medicinal composition for treating cardiovascular diseases and preparation thereof as well as preparation method of preparation |
| 08/31/2011 | CN102166246A Oil-in-water type atractylis oil nano emulsion oral liquid |
| 08/31/2011 | CN102166245A Oil in water type blumea oil nanoemulsion and preparation method thereof |
| 08/31/2011 | CN102166241A Panax notoginseng saponins enteric microcapsule |
| 08/31/2011 | CN102166240A Chinese medicinal composition for treating rectum and anus disease and method for preparing same |
| 08/31/2011 | CN102166233A Oil-in-water type sea buckthorn oil nano-emulsion oral liquid and preparation method thereof |
| 08/31/2011 | CN102166215A Pharmaceutical composition containing piperazine derivatives |
| 08/31/2011 | CN102166212A Method for making benidipine hydrochloride quickly dissolved from tablets |
| 08/31/2011 | CN102166208A Lisinopril and hydrochlorothiazide pharmaceutical composition liposome solid preparation |
| 08/31/2011 | CN102166200A Freeze-drying composition containing cerebroprotein hydrolysates and preparation method of freeze-drying composition |
| 08/31/2011 | CN102166195A Hydroxytyrosol pellets and preparation method thereof |
| 08/31/2011 | CN102166194A Preparation method of anthocyanidin pellet |
| 08/31/2011 | CN101940765B Medicament for treating chronic cerebral circulation insufficiency and preparation method |
| 08/31/2011 | CN101879232B Medicament for dissipating stasis, removing stroke and preventing and treating cardiovascular and cerebrovascular diseases |
| 08/31/2011 | CN101843660B Chinese medicament for treating tachycardia |
| 08/31/2011 | CN101773658B Medicine containing indapamide |
| 08/31/2011 | CN101773657B Medicine containing sodium nitroprusside |
| 08/31/2011 | CN101768209B Hypotensive peptide with high in-vivo activity and preparation and purification method thereof |
| 08/31/2011 | CN101757640B Preparation of clathrate compound containing isoflavone and cyclodextrin of chickpea |
| 08/31/2011 | CN101723918B Process for preparing cinepazide maleate |
| 08/31/2011 | CN101716322B Traditional Chinese medicine composition for treating heart-blood deficiency disease and preparation method thereof |
| 08/31/2011 | CN101711781B Method for extracting and purifying flavonoids compounds by ion-exchange fibers |
| 08/31/2011 | CN101659640B Ozagrel tromethamine, compound, preparation method and application thereof |
| 08/31/2011 | CN101628054B Medicine for treating ischemic stroke and sequela thereof |
| 08/31/2011 | CN101612252B Traditional Chinese medicine external-washing medicinal granules for treating postoperative complication of piles |
| 08/31/2011 | CN101591302B Preparation technique of heptenoic acid ester derivative |
| 08/31/2011 | CN101590158B Method for extracting polyphenol from canna edulis ker waste residue |
| 08/31/2011 | CN101584752B Extraction and purification process for total flavonoids in Anchusa italica Retiz |
| 08/31/2011 | CN101574322B Bevantolol hydrochloride orally disintegrating tablet |
| 08/31/2011 | CN101570510B Quinoline compound, pharmaceutical composition, preparation method and application thereof |
| 08/31/2011 | CN101569641B Medicine composition for treating ishemic stroke and preparation method thereof |
| 08/31/2011 | CN101485832B Capsule for coronary disease |
| 08/31/2011 | CN101461907B Medicament for treating liver-yang hyperactivity, extinguishing liver-wind and nourishing kidney-yin as well as preparation method |
| 08/31/2011 | CN101313940B Traditional Chinese medicine nourishing skin-protection cream |
| 08/31/2011 | CN101310737B Medicine for treating ischemic stroke and its preparation method |
| 08/31/2011 | CN101248876B Norcholesterol health care drink |
| 08/31/2011 | CN101219992B Crystalline forms of pitavastatin calcium |
| 08/31/2011 | CN101161270B Pharmaceutical composition of cattail pollen and kudzu root |
| 08/30/2011 | US8008491 poly(adenosine 5'-diphosphate ribose) polymerase inhibitors such as 1-phenyl-2-(piperazin-1-yl)-1,3-dihydropyrrolo[2,3-b]pyridine-3-carboxaldehyde, used in the treatment and/or prevention central nervous system and cardiovascular disorders |
| 08/30/2011 | US8008483 sEH inhibitors and their use |
| 08/30/2011 | US8008341 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases |
| 08/30/2011 | US8008332 Substituted indazoles as glucokinase activators |
| 08/30/2011 | US8008321 Imidazo[1,5-a]pyridin-3-yl)(3-methoxy-4-nitrophenyl)methanone; a and b fibroblast growth factor receptors (FGFR) antagonist; anticarcinogenic, antitumor: lung, breast, prostate, melanomas, gliomas; antiinflammatory, vascular smooth muscle cells: atherosclerosis, restenosis, stent and bypass complications |
| 08/30/2011 | US8008308 Phosphonate compounds |
| 08/30/2011 | US8008299 Urotensin II receptor antagonists |
| 08/30/2011 | US8008282 Lipoxin analogs as novel inhibitors of angiogenesis |
| 08/30/2011 | US8008254 Methods and compositions for the repair and/or regeneration of damaged myocardium |